Neopterin and Beta-2 Microglobulin Relations to Immunity and Inflammatory Status in Nonischemic Dilated Cardiomyopathy Patients

Table 3

Serum concentrations of immune activation and inflammatory markers in DCM patients with or without myocarditis according to Dallas criteria and controls, median (25th–75th percentiles).

	Active (A); = 20	Borderline (B); = 70	No MCI (N); = 79	A versus N*	Controls (C); = 30	*; **; ***
NPT; nmol/L	5.35; (2.94–12.88)	6.68; (3.96–13.47)	5.06; (2.97–11.38)	ns	4.99; (2.66–8.28)	<0.05**
β-2 M; mg/L	2.98; (2.56–3.59)	2.63; (1.68–3.71)	2.37; (1.14–3.67)	<0.05*	1.75; (1.28–1.96)	<0.001*; <0.001**; <0.05***